Effect of Darapladib onMajor Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial

Michelle L. O’Donoghue, MD, MPH; Eugene Braunwald, MD; Harvey D. White, MBChB, DSc; Dylan L. Steen, MD; Mary Ann Lukas, MD; Elizabeth Tarka, MD; P. Gabriel Steg, MD; Judith S. Hochman, MD; Christoph Bode, MD; Aldo P. Maggioni, MD; KyungAh Im, PhD; Jennifer B. Shannon, MS; Richard Y. Davies, MS; Sabina A. Murphy, MPH; Sharon E. Crugnale, MS; Stephen D. Wiviott, MD; Marc P. Bonaca, MD, MPH; David F. Watson, MSc; W. Douglas Weaver, MD; Patrick W. Serruys, MD, PhD; Christopher P. Cannon, MD; for the SOLID-TIMI 52 Investigators